Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Palisade Bio (PALI) Return on Assets (2016 - 2025)

Historic Return on Assets for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to 1.68%.

  • Palisade Bio's Return on Assets fell 3600.0% to 1.68% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.68%, marking a year-over-year decrease of 3600.0%. This contributed to the annual value of 1.19% for FY2024, which is 3200.0% down from last year.
  • Per Palisade Bio's latest filing, its Return on Assets stood at 1.68% for Q3 2025, which was down 3600.0% from 1.63% recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's Return on Assets ranged from a high of 0.78% in Q3 2023 and a low of 5.45% during Q2 2022
  • Moreover, its 5-year median value for Return on Assets was 1.37% (2024), whereas its average is 1.81%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -29900bps in 2021, then skyrocketed by 45900bps in 2023.
  • Quarter analysis of 5 years shows Palisade Bio's Return on Assets stood at 2.8% in 2021, then soared by 65bps to 0.98% in 2022, then rose by 14bps to 0.84% in 2023, then plummeted by -75bps to 1.47% in 2024, then fell by -14bps to 1.68% in 2025.
  • Its Return on Assets stands at 1.68% for Q3 2025, versus 1.63% for Q2 2025 and 1.42% for Q1 2025.